Tetracyclines: What a rheumatologist needs to know?

International Journal of Rheumatic Diseases

Volumn 12, Issue 2, 2009, Pages 84-89

  Attar, Suzan M ^a  

^a KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Calcinosis; Osteoarthritis; Rheumatoid arthritis; Sarcoidosis; Tetracyclines

Indexed keywords

AZITHROMYCIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DOXYCYCLINE FOSFATEX; MATRIX METALLOPROTEINASE; METHOTREXATE; MINOCYCLINE; PLACEBO; RIFAMPICIN; TETRACYCLINE DERIVATIVE;

ACNE; ANGIOGENESIS; ANOSMIA; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTHRITIS; BONE METABOLISM; BRAIN PSEUDOTUMOR; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DISEASE COURSE; DISEASE DURATION; DIZZINESS; DRUG ABSORPTION; DRUG EFFICACY; DRUG ERUPTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG WITHDRAWAL; ENZYME INHIBITION; EROSION; ERYTHEMA MULTIFORME; ERYTHEMA NODOSUM; ESOPHAGUS EROSION; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL SYMPTOM; HEPATITIS; HUMAN; HYPERPIGMENTATION; HYPOGLYCEMIA; LOW DRUG DOSE; LUNG CANCER; LUPUS LIKE SYNDROME; META ANALYSIS; MONILIA VAGINITIS; MONOTHERAPY; ONYCHOLYSIS; OSTEOARTHRITIS; PHOTOONYCHOLYSIS; PHOTOSENSITIVITY; PNEUMONIA; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; REVIEW; RHABDOMYOLYSIS; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SERONEGATIVE SPONDYLOARTHRITIS; SERUM SICKNESS; SERUM THICKNESS LIKE REACTION; SKIN CALCIFICATION; SKIN DISEASE; SPONDYLARTHRITIS; SYSTEMIC SCLEROSIS; TREATMENT DURATION; TREATMENT RESPONSE; VAGINITIS;

BACTERIAL INFECTIONS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RHEUMATIC DISEASES; RHEUMATOLOGY; TETRACYCLINES;

EID: 67749147351     PISSN: 17561841     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2009.01389.x     Document Type: Review

References (24)

1. Fragoulis KN, Handrinou E, Papadopoulos V, Dardoufas K, Falagas ME (2006) Delayed effusive pericarditis and recurrent pleural effusion after radiation treatment for Hodgkin's disease responsive to per os doxycycline. Eur J Haematol 76, 176-9.
2. Lee CZ, Yao JS, Huang Y, et al. (2006) Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor. Cerebral Blood Flow Metabolism 26, 1157-64.
3. Katzung BG (2004) Basic Clinical Pharmacology, 9th edn. pp. 755-8. McGraw-Hill.
4. Smith K, Leyden JJ (2005) Safety of doxycycline and minocycline: A systematic review. Clin Ther 27, 1329-42.
5. Sapadin AN, Fleischmajer R (2006) Tetracyclines: Nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54, 258-65. Review.
6. Alarcon C (2003) Antibiotics. In: Hochberg M, et.al., eds. Rheumatology, 3rd edn, pp. 491-5. Mosby.
7. Amin AR, Attur MG, Thakker GD, et al. (1996) A novel mechanism of action of tetracyclines effect of nitric oxide synthetase. Proc Natl Acad Sci USA 93, 1401-9.
8. Scheinfeld N (2005) Tigecycline: A review of a new glycylcycline antibiotic. J Dermatolog Treat 16, 207-12.
9. Stone M, Fortin PR, Pacheco-Tena C, Inman RD (2003) Should tetracycline treatment be used more extensively for rheumatoid arthritis. J Rheumatol 30, 2112-22.
10. Kloppenburg M, Breedveld FC, Terwiel JP, Mallee C, Dijkmans BA (1994) Minocycline in active rheumatoid arthritis. A double blind, placebo-controlled trial. Arthritis Rheum 37, 629-36.
11. Tilley BC, Alarcon GS, Heyse SP, Li S, Clegg DO, Alarcon GS (1995) Minocycline in rheumatoid arthritis. A 48-week, double blind, placebo-controlled trial. MIRA Trial Group Ann Intern Med 122, 81-9.
12. O'Dell JR, Haire CE, Palmer W, et.al. (1997) Treatment of early rheumatoid arthritis with minocycline or placebo: Results of a randomized, double blind, placebo-controlled trial. Arthritis Rheum 40, 842-8.
13. O'Dell JR, Blakely KW, Mallek JA, et.al. (2001) Treatment of early sero-positive rheumatoid arthritis: A two-year, double-blind comparison of minocycline and hydroxychloroquine. Arthritis Rheum 44, 2235-41.
14. O'Dell JR, Elliott JR, Mallek JA, et al. (2006) Treatment of early seropositive rheumatoid arthritis: Doxycycline plus methotrexate versus methotrexate alone. Arthritis Rheum 54, 621-7.
15. St Calir EW, Wilkinson WE, Pisetsky DS, et al. (2001) The effects of intravenous doxycycline therapy for rheumatoid arthritis: A randomized, double blind, placebo-controlled trial. Arthritis Rheum 44, 1043-7.
16. Pillemer S, Gulko P, Ligier S, et.al. (2003) Pilot clinical trial of intravenous doxycycline versus placebo for rheumatoid arthritis. J Rheumatol 30, 41-3.
17. Brandt KD, Mazzuca SA, Katz BP, et al. (2005) Effects of Doxycycline on progression of osteoarthritis: Results of a RCT, double-blind trial. Arthritis Rheum 52, 2015-25.
18. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G (2006) Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 19, CD005321.
19. Bachelez H, Senet P, Cadranel J, Kaoukhov A, Dubertret LI (2001) The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 137, 69-73.
20. Baughman RP (2002) Therapeutic options for sarcoidosis: New and old. Curr Opin Pulm Med 8, 464-9.
21. Robertson LP, Marshall RW, Hickling P (2003) Treatment of cutaneous calcinosis in limited systemic sclerosis with minocycline. Ann Rheum Dis 62, 267-9.
22. Mayes MD, O'Donnell D, Rothfield NF, Csuka ME (2004) Minocycline is not effective in systemic sclerosis: Results of an open-label multicenter trial. Arthritis Rheum 50, 553-7.
23. Smieja M, MacPherson DW, Kean W, et al. (2001) Randomized, blinded, placebo controlled trial of doxycycline for chronic sero-negative arthritis. Ann Rheumatic Dis 60, 1088-94.
24. Carter JD, Valeriano J, Vasey FB (2004) Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to chlamydia-induced arthritis. A prospective, randomized 9-month comparison. J Rheumatol 31, 1973-80.